Lv2
172 积分 2022-12-03 加入
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
1天前
待确认
Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review
2天前
已完结
Oleic acid-PPARγ-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment
6天前
已完结
Machine‐learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection
11天前
已完结
Machine‐learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection
18天前
已完结
Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
19天前
已完结
Kaempferol‐Enhanced Migration and Differentiation of C2C12 Myoblasts via ITG1B/FAK/Paxillin and IGF1R/AKT/mTOR Signaling Pathways
20天前
已完结
Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma
23天前
已完结
Prognostic significance of tumour budding, tumour–stroma ratio and desmoplastic stromal reaction in gall bladder carcinoma
24天前
已完结
OS-057-YI CORE: a new risk score measuring GGT, AST, and ALT outperforms FIB-4 when predicting the risk of cirrhosis in a primary care setting
30天前
已完结
皖公网安备34019202002308
